SLC30A8 polymorphism and type 2 diabetes risk: Evidence from 27 study groups
Y.L. Jing,Q.M. Sun,Y. Bi,S.M. Shen,D.L. Zhu
DOI: https://doi.org/10.1016/j.numecd.2009.11.004
2011-01-01
Abstract:Methods and results We searched PubMed through October 2009 to identify all relevant papers. Odds ratios (ORs) and 95% confidence intervals (CIs) were extracted under an additive genetic model. In the current meta-analysis, we identified a total of 27 groups including 42,609 cases and 69,564 controls. In analyses of the case–control studies by ethnicity, the results indicated that SLC30A8 polymorphism was related to elevate risks of type 2 diabetes both in Europeans (OR = 1.15, 95% CI 1.11–1.18, P < 0.001) and Asians (OR = 1.15, 95% CI 1.11–1.19, P < 0.001). Next, we separated hospital-based case–control studies from population-based case–control studies, however, there was no apparent difference between population-based case–control study groups (OR = 1.15, 95% CI 1.12–1.17, P < 0.001) and hospital-based case–control study groups (OR = 1.16, 95% CI 1.07–1.25, P < 0.001). Conclusion Our present meta-analysis provided evidence that SLC30A8 (rs13266634) C allele carriers could elevate the risk of type 2 diabetes, especially in Europeans and Asians. Keywords Type 2 diabetes SLC30A8 (rs13266634) polymorphism Meta-analysis Introduction Type 2 diabetes is a complex disease characterized by insulin resistance and pancreatic β-cell dysfunction, and the prevalence of type 2 diabetes is increasing rapidly worldwide. Many environmental factors combined with multiple genetic variants are involved in the onset and development of type 2 diabetes. To date, intense research has been performed to identify the genetic risk factors in type 2 diabetes, and 18 genetic loci have been reported to be associated with the risk of type 2 diabetes [1,2] . Zinc transporter protein member 8 ( ZnT-8 ), which is a member of the zinc transporter family, is only expressed in pancreatic beta cells and provides zinc to insulin maturation and/or storage processes in insulin-secreting pancreatic beta cells. ZnT-8 ( SLC30A8 ) is a 369-amino acid protein coded by the gene SLC30A8 (chromosome 8q24.11). The non-synonymous single-nucleotide polymorphism (SNP) in SLC30A8 (rs13266634) causes an arginine to tryptophan change (Arg325Trp) in the last exon of the solute carrier family 30 [3,4] . There is accruing evidence that SLC30A8 polymorphism is associated with β-cell dysfunction. Kirchhoff et al. indicated that the risk allele of rs13266634 in SLC30A8 plays an important role in impaired proinsulin conversion and processing [5] . In addition, the polymorphism of SLC30A8 was also associated with the secretion of insulin. In the study of 846 non-diabetic but diabetes-prone European offspring of type 2 diabetic patients, they found that the function and/or production of ZnT-8 were reduced when carrying the risk C allele of SLC30A8 . The risk C allele might also modulate the function of neighboring cells via paracrine/autocrine interactions, and variation in ZnT-8 is a cause of impaired pancreatic beta cell function. The SLC30A8 loci were also related to altered glucose-stimulated insulin secretion [6,7] . A recent genome-wide association study of the French population by Sladek et al. identified four novel risk loci for type 2 diabetes, and rs13266634 in the SLC30A8 gene locus has been found to be associated with type 2 diabetes [8] . Subsequently, replication studies on the association between SLC30A8 (rs13266634) polymorphism and type 2 diabetes susceptibility have been performed in various ethnic populations, but the results were inconclusive, which might be due to the relatively small sample size in the included studies. Therefore, it is critical to summarize the available evidence from case–control studies and prospective studies to further estimate the association between SLC30A8 polymorphism and susceptibility to type 2 diabetes. In the present study, we conducted a meta-analysis on SLC30A8 (rs13266634) polymorphism and type 2 diabetes susceptibility based on various ethnic groups from Europe, Asia and Africa [8–29] . Methods Search strategy We searched PubMed through October 2009 to identify all relevant papers, using the key words Zinc transporter protein member 8, ZnT-8 , SLC30A8 , SLC30A8 gene polymorphism or SLC30A8 variant in combination with diabetes or type 2 diabetes or T2DM. The titles and abstracts were scanned to exclude studies that were clearly irrelevant to the current topic. The full text of the remaining articles was read to determine whether they contained information of interest. Additionally, the reference lists of the retrieved articles were examined to identify other relevant publications. We performed a systematic literature search for all relevant studies in the English language. All searches were conducted independently by two investigators. Study selection To be eligible, studies had to fulfill the following criteria: 1) had a case–control study design or prospective study design; 2) reported the number of subjects with each allele or genotype in cases and controls; 3) reported the risk estimates [odds ratio (OR)] and 95% confidence intervals (CI) or provided raw data that allowed us to calculate them. Studies were excluded if there were no available data reported. When the same data were included in more than one publication, the complete or most recent study was included. We also conducted a meta-regression to identify characteristics (body mass index (BMI), age) that significantly contributed to heterogeneity. Data extraction The following data were extracted independently by two authors following the guidelines of the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group: first author's name, publication year, ethnicity of the study population, study design (population-based controls or hospital-based controls for case–control studies and prospective studies), numbers of cases and controls or prospective cohort size, the number of cases and controls with each of the three genotypes, allele frequencies and the most completely adjusted estimate (OR and 95% CI) [30] . Discrepancies were reconciled through discussion and resolved by a third investigator until consensus was achieved on every item. Statistical analysis ORs with 95% CIs were used to assess the strength of the association between SLC30A8 polymorphism and the risk of type 2 diabetes in both case–control studies and prospective studies. Study-specific ORs and corresponding 95% CIs were extracted from every included study and then log OR values were weighted by the inverse of their variances to obtain a pooled OR and its 95% CI. The Z -test was used to determine the statistical significance of the pooled OR, and P < 0.05 was considered as statistically significant. We evaluated the association between C/T allele and type 2 diabetes risk under an additive genetic model. Overall OR and 95% CI were directly extracted from 17 studies [9–15,17,18,20,21,23–27,29] . In order to improve comparability with other studies, we calculated the total OR and 95% CI with the information provided under the additive genetic model in the remaining five studies [8,16,19,22,28] . We performed analysis on ethnicity (Europeans, Asians and Africans) separately. Stratified analysis was conducted on the source of controls (hospital-based or population-based) in case–control studies. The Q test ( P < 0.10 was considered representative of statistically significant heterogeneity) and I 2 statistic were used to evaluate possible heterogeneity of study results [31] . If significant heterogeneity existed, the pooled OR estimate of each study was calculated by the random-effects model, otherwise the fixed-effects model was used [32] . We also performed sensitivity analyses to assess the stability of the results. The Funnel plot and Egger regression test were used to assess potential publication bias, and P < 0.10 was considered as a statistically significant publication bias [33] . All of the statistical analyses were conducted with STATA 9.2 software (STATA Corporation, College Station, TX, USA). Results We identified 44 potentially relevant studies after the primary literature search. Nineteen studies were excluded after screening abstracts and full texts, because they were either review articles, or irrelevant to our current study. Three studies [34–36] were excluded because they focused on SLC30A8 polymorphism and type 1 diabetes risk. One study was not included because it defined hyperglycemia (HG) as IFG or T2D. [37] We also performed a stepwise process sensitivity analysis, and the result indicated that the second group in the study by Cauchi et al. [19] was the main source of the heterogeneity in the European groups, so it was excluded in the meta-analysis. Therefore, there were a total of 24 groups from 20 case–control studies [8–27] and three groups from two prospective studies [28,29] including 42,609 cases and 69,564 controls in the current meta-analysis on SLC30A8 polymorphism in relation to susceptibility to type 2 diabetes risk ( Table 1 ). There were duplicated numbers of cases and/or controls in five studies [8,13,17,19,22] , so the large numbers were extracted when summarizing the total number of cases and controls. Among the case–control studies, three groups were hospital-based case–control samples and 21 were population-based case–control samples. In the case–control studies, 12 groups were Asian descendents, 10 were European descendents and the remaining two were African descendents. Subjects in the two prospective studies were European descendents. Age, sex and BMI were considered as the potential confounders in most of the individual studies. In several studies, BMI and age have been demonstrated to be involved in type 2 diabetes and its complications [38–41] , so we attempted to take these covariates into account by meta-regression; however, we failed to find any significant results. The genotypic distributions in the controls of all included studies were in agreement with Hardy–Weinberg equilibrium except for two studies by Ng et al. and Horikawa et al., but the summarized estimates were not significantly changed with or without the inclusion of these two studies [17,20] . In the analyses of the case–control studies by ethnicity (European, Asian and African), the results indicated that SLC30A8 polymorphism was related to elevated risks of type 2 diabetes both in European groups (OR = 1.15, 95% CI, 1.11–1.18, Z = 8.31, P < 0.001) and Asian groups (OR = 1.15, 95% CI, 1.11–1.19, Z = 7.54, P < 0.001) ( Fig. 1 ), however, the results from the African groups showed no statistically significant association between SLC30A8 polymorphism and type 2 diabetes risk (OR = 1.09, 95% CI, 0.89–1.33, Z = 0.83, P = 0.404) ( Table 2 ). When we separated hospital-based case–control studies from population-based case–control studies, there was a statistically significant association in the population-based case–control study groups (OR = 1.15, 95% CI, 1.12–1.17, Z = 11.42, P < 0.001) ( Fig. 2 ), and a similar result was observed in the hospital-based case–control study groups (OR = 1.16, 95% CI, 1.07–1.25, Z = 3.69, P < 0.001) ( Fig. 2 ). Of all the included studies, no evidence of obvious asymmetry was observed which indicated that no publication bias was revealed by Egger's test ( t = −0.65, P = 0.519). Discussion The current meta-analysis including 24 case–control studies and three prospective studies was conducted to explore the association between SLC30A8 polymorphism and susceptibility to type 2 diabetes. The results indicated that SLC30A8 polymorphism carried an elevated risk of type 2 diabetes in both hospital-based and population-based case–control studies, which indicated that individuals with the variant genotype had a higher risk for the development of type 2 diabetes than participants with the wild genotype. The pooled OR on the analysis by ethnicity indicated that the elevated risk existed both in Europeans and Asians, but not in Africans. Since rs13266634 in the SLC30A8 gene locus was identified as one of the risk loci for type 2 diabetes, the function of ZnT-8 and the SNP of this gene have been widely studied in the etiology of type 2 diabetes. In two cohort studies from the Insulin Resistance Atherosclerosis Family Study, the non-synonymous variant at the SLC30A8 locus was associated with variation in disposition index (an index of beta-cell function) in an African-American cohort and more modestly in a Hispanic-American cohort [42] . Recently, a three-stage genome-wide association study was conducted to identify novel type 2 diabetes gene variants and confirm previously identified variants in the Japanese population; the authors confirmed the association between the SLC30A8 variant and type 2 diabetes risk [43] . Evidence from animal studies confirmed that ZnT-8 modulated glucose homeostasis in mice, and it was required for normal insulin crystallization and insulin release mainly in vivo . Additionally, down-regulation of ZnT-8 expression was associated with a marked decrease in intracellular insulin content and a reduction in the secretion of insulin in cultured rat beta-cell line cells. Moreover, SLC30A8 expression-level polymorphism could affect insulin secretion and the glycemic response in vivo by reducing the endogenous expression of the ZnT-8 transporter [44,45] . The results in our present study should be interpreted with caution when heterogeneity is present. Obvious heterogeneity was observed in European groups, however, after exclusion of one study group that caused the heterogeneity, no evidence of heterogeneity was observed ( P = 0.300). This implies that different genetic backgrounds and various environmental factors were present in different ethnicities, and a small study sample was also a source of heterogeneity. Some limitations of this meta-analysis must be considered when interpreting the results. First, our search was limited to English-language studies and papers published in indexed journals, and we were not able to obtain the original data. Second, all studies which we included were observational studies, which presented particular challenges because of different study designs and inherent biases, however, no publication bias was observed in our study, suggesting that the overall result is likely to be unbiased. Third, study samples were relatively small when investigating the relationship between the two factors in Africans, so a more precise association needs to be explored further with sufficient data. Fourth, we were not able to conduct subgroup analyses on obesity status because of insufficient data and different definitions of obesity status among different ethnicities; only one study separated obese from non-obese participants [22] , so whether obesity status affects the genetic susceptibility to type 2 diabetes needs further research. Fifth, there was statistically significant heterogeneity among the European group, which may be attributed to the multiple ethnic groups in the world, the complicated interactions between gene–gene and gene–environment, the limited study numbers and relatively small sample sizes. Variable definition of cases and controls might also be a source of heterogeneity. In addition, the numbers of prospective studies were too limited to perform analysis on ethnicity and the source of controls so as to certify the results of the case–control studies. Sixth, not all of the included studies have adjusted for potential confounders, such as age, sex, BMI (body mass index), family history, environmental factors and lifestyle, all of which could influence the relationship between SLC30A8 polymorphism and the risk of type 2 diabetes. In conclusion, our data indicated an elevated risk of type 2 diabetes in carriers of an SLC30A8 (rs13266634) C allele, especially in Europeans and Asians. However, further large sample prospective studies on different ethnic groups are warranted to confirm our results. In addition, comprehensive interactions on gene–gene and gene–environment should also be evaluated in future analyses. Acknowledgements This work was supported by grants from the National Natural Science Foundation of China (No. 30671004 and No. 30800539), the development program of Nanjing Health Bureau (No. ZKX05022) and the Natural Science Foundation of Jiangsu Province (No. BK2008061). Conflict of interest None disclosed. References [1] M.A. Permutt J. Wasson N. Cox Genetic epidemiology of diabetes J Clin Invest 115 2005 1431 1439 [2] J.R. Perry T.M. Frayling New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function Curr Opin Clin Nutr Metab Care 11 2008 371 377 [3] T.W. Boesgaard J. Zilinskaite M. Vänttinen M. Laakso P.A. Jansson A. Hammarstedt The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients – the EUGENE2 study Diabetologia 51 2008 816 820 [4] H. Staiger F. Machicao N. Stefan O. Tschritter C. Thamer K. Kantartzis Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function PLoS One 2 2007 e832 [5] K. Kirchhoff F. Machicao A. Haupt S.A. Schäfer O. Tschritter H. Staiger Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion Diabetologia 51 2008 597 601 [6] E. Mocchegiani R. Giacconi M. Malavolta Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes Trends Mol Med 14 2008 419 428 [7] F. Chimienti A. Favier M. Seve ZnT-8, a pancreatic beta-cell-specific zinc transporter Biometals 18 2005 313 317 [8] R. Sladek G. Rocheleau J. Rung C. Dina L. Shen D. Serre A genome-wide association study identifies novel risk loci for type 2 diabetes Nature 445 2007 881 885 [9] L.J. Scott K.L. Mohlke L.L. Bonnycastle C.J. Willer Y. Li W.L. Duren A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants Science 316 2007 1341 1345 [10] R. Saxena B.F. Voight V. Lyssenko N.P. Burtt P.I. de Bakker H. Chen Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels Science 316 2007 1331 1336 [11] E. Zeggini M.N. Weedon C.M. Lindgren T.M. Frayling K.S. Elliott H. Lango Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes Science 316 2007 1336 1341 [12] M. Horikoshi K. Hara C. Ito N. Shojima R. Nagai K. Ueki Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population Diabetologia 50 2007 2461 2466 [13] V. Steinthorsdottir G. Thorleifsson I. Reynisdottir R. Benediktsson T. Jonsdottir G.B. Walters A variant in CDKAL1 influences insulin response and risk of type 2 diabetes Nat Genet 39 2007 770 775 [14] J.K. Hertel S. Johansson H. Raeder K. Midthjell V. Lyssenko L. Groop Genetic analysis of recently identified type 2 diabetes loci in 1638 unselected patients with type 2 diabetes and 1858 control participants from a Norwegian population-based cohort (the HUNT study) Diabetologia 51 2008 971 977 [15] Y.H. Lee E.S. Kang S.H. Kim S.J. Han C.H. Kim H.J. Kim Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population J Hum Genet 53 2008 991 998 [16] D.K. Sanghera L. Ortega S. Han J. Singh S.K. Ralhan G.S. Wander Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk BMC Med Genet 9 2008 59 [17] M.C. Ng K.S. Park B. Oh C.H. Tam Y.M. Cho H.D. Shin Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6719 Asians Diabetes 57 2008 2226 2233 [18] Y. Furukawa T. Shimada H. Furuta S. Matsuno A. Kusuyama A. Doi Polymorphisms in the IDE-KIF11-HHEX gene locus are reproducibly associated with type 2 diabetes in a Japanese population J Clin Endocrinol Metab 93 2008 310 314 [19] S. Cauchi D. Meyre E. Durand C. Proença M. Marre S. Hadjadj Post genome-wide association studies of novel genes associated with type 2 diabetes show gene–gene interaction and high predictive value PLoS One 3 2008 e2031 [20] Y. Horikawa K. Miyake K. Yasuda M. Enya Y. Hirota K. Yamagata Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan J Clin Endocrinol Metab 93 2008 3136 3141 [21] J.P. Lewis N.D. Palmer P.J. Hicks M.M. Sale C.D. Langefeld B.I. Freedman Association analysis in African Americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies Diabetes 57 2008 2220 2225 [22] S. Cauchi K.T. Nead H. Choquet F. Horber N. Potoczna B. Balkau The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies BMC Med Genet 9 2008 45 [23] Y. Wu H. Li R.J. Loos Z. Yu X. Ye L. Chen Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX / IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population Diabetes 57 2008 2834 2842 [24] J. Xiang X.Y. Li M. Xu J. Hong Y. Huang J.R. Tan Zinc transporter-8 gene (SLC30A8) is associated with type 2 diabetes in Chinese J Clin Endocrinol Metab 93 2008 4107 4112 [25] S. Omori Y. Tanaka A. Takahashi H. Hirose A. Kashiwagi K. Kaku Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population Diabetes 57 2008 791 795 [26] R. Rong R.L. Hanson D. Ortiz C. Wiedrich S. Kobes W.C. Knowler Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians Diabetes 58 2009 478 488 [27] Y. Tabara H. Osawa R. Kawamoto H. Onuma I. Shimizu T. Miki Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening Diabetes 58 2009 493 498 [28] M. van Hoek A. Dehghan J.C. Witteman C.M. van Duijn A.G. Uitterlinden B.A. Oostra Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study Diabetes 57 2008 3122 3128 [29] V. Lyssenko A. Jonsson P. Almgren N. Pulizzi B. Isomaa T. Tuomi Clinical risk factors, DNA variants, and the development of type 2 diabetes N Engl J Med 359 2008 2220 2232 [30] D.F. Stroup J.A. Berlin S.C. Morton I. Olkin G.D. Williamson D. Rennie Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012 [31] J.P. Higgins S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558 [32] D. Petitti Meta-analysis, decision analysis, and cost-effectiveness analysis 1994 Oxford University Press New York [33] M. Egger G. Davey Smith M. Schneider C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634 [34] H. Gohlke U. Ferrari K. Koczwara E. Bonifacio T. Illig A.G. Ziegler SLC30A8 (ZnT8) Polymorphism is associated with young age at type 1 diabetes onset Rev Diabet Stud 5 2008 25 27 [35] C. Brorsson R. Bergholdt M. Sjögren S. Eising K.M. Sørensen D.M. Hougaard A non-synonymous variant in SLC30A8 is not associated with type 1 diabetes in the Danish population Mol Genet Metab 94 2008 386 388 [36] H.Q. Qu S.F. Grant J.P. Bradfield C. Kim E. Frackelton H. Hakonarson Association analysis of type 2 diabetes Loci in type 1 diabetes Diabetes 57 2008 1983 1986 [37] S. Cauchi C. Proença H. Choquet S. Gaget F. De Graeve M. Marre Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study J Mol Med 86 2008 341 348 [38] Lin CY, Chen PC, Kuo HK, Lin LY, Lin JW, Hwang JJ. Effects of obesity, physical activity, and cardiorespiratory fitness on blood pressure, inflammation, and insulin resistance in the National Health and Nutrition Survey 1999–2002. Nutr Metab Cardiovasc Dis in press, doi:10.1016/j.numecd.2009.06.005 . [39] E. Morini S. Prudente E. Succurro M. Chandalia Y.Y. Zhang S. Mammarella IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of ‘low-frequency-low-risk’ variants Diabetologia 52 2009 1852 1857 [40] J.B. McAteer S. Prudente S. Bacci H.N. Lyon J.N. Hirschhorn V. Trischitta The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects Diabetes 57 2008 1125 1130 [41] Rossi MC, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, et al. Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND Study. Nutr Metab Cardiovasc Dis in press, doi:10.1016/j.numecd.2009.02.013 . [42] N.D. Palmer M.O. Goodarzi C.D. Langefeld J. Ziegler J.M. Norris S.M. Haffner Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study Diabetes 57 2008 1093 1100 [43] F. Takeuchi M. Serizawa K. Yamamoto T. Fujisawa E. Nakashima K. Ohnaka Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population Diabetes 58 2009 1690 1699 [44] T.J. Nicolson E.A. Bellomo N. Wijesekara M.K. Loder J.M. Baldwin A.V. Gyulkhandanyan Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants Diabetes 58 2009 2070 2083 [45] Y. Fu W. Tian E.B. Pratt L.B. Dirling S.L. Shyng C.K. Meshul Down-regulation of ZnT8 expression in INS-1 rat pancreatic beta cells reduces insulin content and glucose-inducible insulin secretion PLoS One 4 2009 e5679
What problem does this paper attempt to address?
-
Association of MTHFR C677T Polymorphism and Type 2 Diabetes Mellitus (T2DM) Susceptibility
Yanzi Meng,Xiaoling Liu,Kai Ma,Lili Zhang,Mao Lu,Minsu Zhao,Min-Xin Guan,Guijun Qin
DOI: https://doi.org/10.1002/mgg3.1020
2019-01-01
Molecular Genetics & Genomic Medicine
Abstract:Abstract Introduction Methylenetetrahydrofolate reductase (MTHFR) is essential in mediating folate metabolism, and thus plays an important role in diabetes and diabetic complications. MTHFR C677T (rs1801133 C>T) polymorphism has been proposed to be linked with type 2 diabetes mellitus (T2DM) susceptibility. However, the conclusions are inconsistent. Therefore, we rechecked their linkage aiming to obtain a more reliable estimation by performing an updated meta‐analysis. Methods We searched electronic databases PubMed, EMBASE, CNKI, and Wanfang to obtain studies updated to October 2019. Results After carefully screening, we finally incorporated 68 studies with 10,812 cases and 8,745 controls. The genotype frequency of C677T polymorphism was analyzed pooled to generate odds ratios (ORs) and 95% confidence intervals (CIs). Pooled results presented that MTHFR C677T polymorphism was significantly associated with T2DM under homozygous (OR = 1.64, 95% CI = 1.39–1.94), heterozygous (OR = 1.38, 95% CI = 1.20–1.59), recessive (OR = 1.41, 95% CI = 1.23–1.61), dominant (OR = 1.47, 95% CI = 1.27–1.70), and allele (OR = 1.37, 95% CI = 1.23–1.52) genetic models. Stratified analysis demonstrated that C677T genotype was associated with T2DM in Asian populations, but not Caucasian and African populations. Conclusion Our results indicated that MTHFR C677T polymorphism confers to T2DM, especially in Asian populations. Much more large‐scale case–control studies are needed to strengthen such conclusion in the future.
-
Association of SLC30A8 Gene Polymorphism with Type 2 Diabetes, Evidence from 46 Studies: a Meta-Analysis
Mengdi Fan,Weimin Li,Lian Wang,Suping Gu,Sisi Dong,Mengdie Chen,Haimin Yin,Jinjue Zheng,Xiaoying Wu,Jian Jin,Xuchao Jiang,Jiao Cai,Peining Liu,Chao Zheng
DOI: https://doi.org/10.1007/s12020-016-0870-4
2016-01-01
Endocrine
Abstract:The solute carrier family 30 member 8 (SLC30A8) gene may be involved in the development of type 2 diabetes mellitus (T2DM) through disrupting β-cell function. The aim of this study was to assess the association between SLC30A8 rs13266634 polymorphism and susceptibility to T2DM. We searched all reports regarding the association between SLC30A8 rs13266634 polymorphism and T2DM risk through Pubmed, Embase, and the Cochrane Library for English language reports and Chongqing VIP database, Wanfang data, CBMDisc, and CNKI for Chinese language studies. Allelic and genotype comparisons between cases and controls were evaluated, and odds ratios with 95 % confidence intervals were used to assess the strength of their association. A random effects model was selected. Publication bias was estimated using Begg’s test. Forty-six studies were included in the analysis with a total of 71,890 cases and 96,753 controls. This meta-analysis suggests that SLC30A8 (rs13266634) polymorphism was associated with T2DM risk. Although previous meta-analyses have shown that this association was only found in Asian and European groups, and not in African populations, our analysis revealed the deleterious effect of SLC30A8 rs13266634 on T2DM in an African population when stratified by ethnicity under additive model even with a small number of studies.
-
Association between "solute carrier family 30 member 8" (SLC30A8) gene polymorphism and susceptibility to type 2 diabetes mellitus in Chinese Han and minority populations: an updated meta-analysis.
Yan Wang,Leizhen Duan,Songcheng Yu,Xinxin Liu,Han Han,Jun Wang,Wenjie Li
DOI: https://doi.org/10.6133/apjcn.201811_27(6).0025
2018-01-01
Asia Pacific Journal of Clinical Nutrition
Abstract:Background and Objectives: In China, some studies have been reported that solute carrier family 30 member 8 (SLC30A8) gene polymorphism might increase the risk of T2DM, but some are not. The aim of this meta-analysis was to systematically investigate the association between the rs13266634 polymorphism of the SLC30A8 gene and T2DM in Chinese Han and ethnic minority populations. Methods and Study Design: All published electronic articles were retrieved from Pubmed, Web of Knowledge, Chinese National Knowledge Infrastructure (CNKI), Wanfang database, VIP database and Google scholar. Pooled OR and 95% CI were calculated using random-or fixed-effects models. Results: Twenty-five articles involving 62,285 subjects were included in this meta analysis. Considering the total population, significant associations between the rs13266634 polymorphism and T2DM were observed under the allele model (C vs T: OR=1.23, 95% CI=1.18-1.29), the additive models (CC vs TT: OR=1.44, 95% CI=1.32-1.56; CC vs CT: OR=1.08, 95% CI=1.02-1.15; CT vs TT: OR=1.25, 95% CI=1.151.37), the dominant model (CC vs CT+TT: OR=1.24, 95% CI=1.17-1.32) and the recessive model (CC+CT vs TT: OR=1.26, 95% CI=1.16-1.35). Based on subgroup analysis, besides the CC vs CT model, these associations were stronger in the ethnic minority groups than in the Han population. Moreover, no association was observed under the CC vs CT model (OR=1.26, 95% CI=0.95-1.66, p=0.105) in ethnic minority groups. Conclusions: Chinese C allele carriers could have an increased risk of T2DM. Well-designed future studies should be conducted with a larger sample size to better understand this association in ethnic minority groups.
-
Association of KCNJ11 Gene Polymorphisms with the Risk of Type 2 Diabetes Mellitus: A PRISMA-driven Systematic Review of 30,373 Individuals
Lu Zhang,Cuiju Wang,Rufan Cao,Shiyao Chen,Liangqing Guo,Xiaochun Han
DOI: https://doi.org/10.1109/bibm58861.2023.10385330
2023-01-01
Abstract:Background: A large number of studies have investigated the relationship between the polymorphism of potassium ion inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) and the susceptibility to type 2 diabetes mellitus (T2DM), but the results are still controversial. Objective: We studied three gene polymorphisms:rs5219, rs5218, rs5215, and analyzed the allele genetic model, dominant genetic model and recessive genetic model respectively to research the association of the KCNJ11 gene polymorphism with T2D risk. Eligibility criteria: Relevant information of selected articles were independently extracted by 2 reviewers following a predetermined standardized data extraction form. Data sources: We researched databases through PubMed, Web of Science so as to identify all relevant articles published from January 2005 to October 2019. Review appraisl:We used a 95% confidence interval (CI) of the odds ratio (OR) to evaluate the strength of association between these three polymorphisms and T2DM. Z test was used to determine the significance of OR. Q test and I 2 test were used to evaluate inter-study heterogeneity. Eeggr’s test and Begg’s test were used to evaluate publication bias. Results:28 relevant studies which involved 30,373 patients, including 16,155 cases and 14,218 groups were included. The results showed that KCNJ11 rs5219 (OR: 1.15, 95%Cl: 1.07-1.23, P = 0.000)and rs5215 (OR: 1.48, 95%CI: 1.10-1.99, P=0.009)were strongly associated with T2DM, while there was no significant association between rs5218 (OR: 0.85, 95%CI: 0.75-0.96, P = 0.008)and T2DM. Dominant genetic model and recessive genetic model were consistent with these results. Besides, subgroup analysis (Caucasian, East Asian, North African and Others) and sensitivity analysis were consistent with the above results as well. Limitations: Due to the quantity and quality of literature, we only analyzed three polymorphisms (rs5219 rs5218 rs5215), while the others could not be explained because of insufficient literature. Conclusions: This meta-analysis confirmed that KCNJ11 rs5219 and rs5215 polymorphism (SNPs) were significantly associated with the risk of T2DM.
-
Meta-analysis of the association between the rs7903146 polymorphism at the TCF7L2 locus and type 2 diabetes mellitus susceptibility
X H Liu,C G Xie,Y An,X X Zhang,W B Wu
DOI: https://doi.org/10.4238/2015.December.14.12
2015-12-14
Abstract:Type 2 diabetes mellitus (T2DM) is a chronic disease caused by genetic and environmental factors. T2DM has been associated with specific polymorphisms in the TCF7L2 gene. This study evaluates the relationship between the rs7903146 locus polymorphism of the TCF7L2 gene and T2DM susceptibility through meta-analysis; the overall aim is to provide a basis for evidence-based medicinal treatment of T2DM. Cohort and case-control studies from Medline, PubMed, EMBASE, CBM, CNKI, and academic conferences/dissertations that examined the correlation between T2DM and rs7903146 polymorphisms were evaluated. We determined whether the TCF7L2 rs7903146 locus was associated with T2DM susceptibility by comparing alleles and genotypes. The Stata 11.0 software was applied for meta-analysis, and a random-effects model was adopted for heterogeneity testing and odds ratio (OR) calculation. A fixed-effect model was used for quantitative analysis of the heterogeneity between different studies, and for calculating the percentage of variability I(2). A total of 10 studies related to the rs7903146 loci and T2DM susceptibility were enrolled; this included 3404 cases of T2DM patients and 6473 control cases. Meta-analysis showed that the T allele of rs7903146 was significantly correlated with the risk of T2DM, with both a dominant fixed-effect model (OR = 1.653, 95%CI = 1.416-1.653) and a co-dominant-fixed effect model (OR = 1.525, 95%CI = 1.350-1.723). Meta-analysis revealed that the T allele of rs7903146 was also correlated with T2DM susceptibility.
-
Zinc transporter-8 gene (SLC30A8) is associated with type 2 diabetes in Chinese.
Jie Xiang,Xiao-Ying Li,Min Xu,Jie Hong,Yun Huang,Jiao-Rong Tan,Xi Lu,Meng Dai,Bing Yu,Guang Ning
DOI: https://doi.org/10.1210/jc.2008-0161
2013-01-01
Abstract:Context: Several genome-wide association studies identified a strong association of SLC30A8 with type 2 diabetes in individuals of European ancestry. The effect of the association of rs13266634 with type 2 diabetes or related glycemic traits has not been fully extended to non-European populations, and a comprehensive examination of common variants in the gene has not yet been carried out in Han Chinese. Objective: The objective of the study was to investigate the association of SLC30A8 with type 2 diabetes in Chinese. Design: A comprehensive gene-based association study was performed using 14 tagging single-nucleotide polymorphism (SNPs) of SLC30A8 in Han Chinese subjects with normal glucose tolerance (NGT; n = 721), impaired glucose regulation (IGR; n = 375), and type 2 diabetes (n = 521). Results: A significant association for SNP rs13266634 was observed between patients with type 2 diabetes and NGT controls (P = 0.016). The association was also observed between combined type 2 diabetes/IGR and NGT subjects (P = 0.002). The adjusted odds ratios for homozygote CC vs. TT at this locus were 1.71 for type 2 diabetes (95% confidence interval 1.19-2.45, P = 0.002) and 1.77 for type 2 diabetes and IGR (95% confidence interval 1.29-2.42, P = 0.0001). We further studied the genotype-phenotype correlation in 70 Han Chinese using iv glucose tolerance test and found an association between SNP rs13266634 and acute insulin response to glucose and disposition index (adjusted P = 0.012 and 0.004, respectively). Conclusions: Our results provide evidence that SLC30A8 is a susceptible locus for type 2 diabetes in Chinese population, and its variant can influence insulin secretion.
-
TCF7L2 Gene Polymorphisms and Type 2 Diabetes Risk: a Comprehensive and Updated Meta-Analysis Involving 121 174 Subjects
Sihua Peng,Yimin Zhu,Bingjian Lu,Fangying Xu,Xiaobo Li,Maode Lai
DOI: https://doi.org/10.1093/mutage/ges048
2012-01-01
Mutagenesis
Abstract:Recently, many new loci associated with type 2 diabetes have been uncovered by genetic association studies and genome-wide association studies. As more reports are made, particularly with respect to varying ethnicities, there is a need to determine more precisely the effect sizes in each major racial group. In addition, some reports have claimed ethnic-specific associations with alternative single-nucleotide polymorphisms (SNPs), and to that end there has been a degree of confusion. We conducted a meta-analysis using an additive genetic model. Eight polymorphisms in 155 studies with 121174 subjects (53385 cases and 67789 controls) were addressed in this meta-analysis. Significant associations were found between type 2 diabetes and rs7903146, rs12255372, rs11196205, rs7901695, rs7895340 and rs4506565, with summary odds ratios (ORs) (95% confidence interval) of 1.39 (1.34-1.45), 1.33 (1.27-1.40), 1.20 (1.14-1.26), 1.32 (1.25-1.39), 1.21 (1.13-1.29) and 1.39 (1.29-1.49), respectively. In addition, no significant associations were found between the two polymorphisms (rs290487 and rs11196218) and type 2 diabetes. The summary ORs for the six statistically significant associations (P < 0.05) were further evaluated by estimating the false-positive report probability, with results indicating that all of the six significant associations were considered noteworthy, and may plausibly be true associations. Significant associations were found between the six polymorphisms (rs7903146, rs12255372, rs11196205, rs7901695, rs7895340 and rs4506565) in the TCF7L2 gene and type 2 diabetes risk, and the other two polymorphisms (rs11196218 and rs290487) were not found to be significantly associated with type 2 diabetes. Subgroups analyses show that significant associations are not found between the six SNPs (rs7903146, rs12255372, rs11196205, rs7901695, rs7895340, and rs4506565) and the type 2 diabetes in some ethnic populations.
-
A Genetic Variant in SLC6A20 is Associated with Type 2 Diabetes in White‐european and Chinese Populations
Y. Ling,T. T. W. van Herpt,M. van Hoek,A. Dehghan,A. Hofman,A. G. Uitterlinden,S. Jiang,A. G. Lieverse,B. Bravenboer,D. Lu,C. M. van Duijn,X. Gao,E. J. G. Sijbrands
DOI: https://doi.org/10.1111/dme.12528
IF: 3.5
2014-01-01
Diabetic Medicine
Abstract:AimsTo investigate whether polymorphisms in SLC6A20 are associated with susceptibility to Type 2 diabetes.MethodsIn the Rotterdam Study, a prospective, population-based cohort (n=5974), 22 tagging polymorphisms with minor allele frequencies>0.05 across SLC6A20 were studied. Replication studies were performed in an independent Dutch case-control study (DiaGene-Rotterdam Study 2 n=3133), and in a Chinese Han case-control population (n=2279). A meta-analysis of the results was performed.ResultsIn the Rotterdam study, the minor alleles of rs13062383, rs10461016 and rs2286489 increased the risk of Type 2 diabetes (hazard ratio 1.37, 95% CI 1.15-1.63, hazard ratio 1.30 95% CI 1.09-1.54 and hazard ratio 1.20, 95% CI 1.07-1.35, respectively). In the DiaGene/Rotterdam Study 2, the A allele of rs13062383 increased the risk of Type 2 diabetes (odds ratio 1.45, 95% CI 1.19-1.76). In the Chinese Han study, the rs13062383 A allele also increased the risk of Type 2 diabetes (odds ratio 1.21, 95% CI 1.03-1.42). Meta-analysis showed a highly significant association of rs13062383 with Type 2 diabetes (odds ratio 1.35, 95% CI 1.21-1.47; P=3.3x10(-8)).ConclusionsIn conclusion, rs13062383 in SLC6A20 increased the susceptibility to Type 2 diabetes in populations with different genetic backgrounds.
-
Does Genetic Heterogeneity Account for the Divergent Risk of Type 2 Diabetes in South Asian and White European Populations?
Zahra N. Sohani,Wei Q. Deng,Guillaume Pare,David Meyre,Hertzel C. Gerstein,Sonia S. Anand
DOI: https://doi.org/10.1007/s00125-014-3354-1
IF: 8.2
2014-01-01
Diabetologia
Abstract:AIMS/HYPOTHESIS:South Asians are up to four times more likely to develop type 2 diabetes than white Europeans. It is postulated that the higher prevalence results from greater genetic risk. To evaluate this hypothesis, we: (1) systematically reviewed the literature for single nucleotide polymorphisms (SNPs) predisposing to type 2 diabetes in South Asians; (2) compared risk estimates, risk alleles and risk allele frequencies of predisposing SNPs between South Asians and white Europeans; and (3) tested the association of novel SNPs discovered from South Asians in white Europeans.METHODS:MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature (CINAHL) and the Cochrane registry were searched for studies of genetic variants associated with type 2 diabetes in South Asians. Meta-analysis estimates for common and novel bi-allelic SNPs in South Asians were compared with white Europeans from the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) consortium. The population burden from predisposing SNPs was assessed using a genotype score.RESULTS:Twenty-four SNPs from 21 loci were associated with type 2 diabetes in South Asians after meta-analysis. The majority of SNPs increase odds of the disorder by 15-35% per risk allele. No substantial differences appear to exist in risk estimates between South Asians and white Europeans from SNPs common to both groups, and the population burden also does not differ. Eight of the 24 are novel SNPs discovered from South Asian genome-wide association studies, some of which show nominal associations with type 2 diabetes in white Europeans.CONCLUSIONS/INTERPRETATION:Based on current literature there is no strong evidence to indicate that South Asians possess a greater genetic risk of type 2 diabetes than white Europeans.
-
Association of CDKAL1 RS10946398 Gene Polymorphism with Susceptibility to Diabetes Mellitus Type 2: A Meta-Analysis
Ning Xu,Ting-Ting Zhang,Wen-Jia Han,Li-Ping Yin,Nan-Zheng Ma,Xiu-Yan Shi,Jiang-Jie Sun
DOI: https://doi.org/10.1155/2021/1254968
IF: 4.0608
2021-12-24
Journal of Diabetes Research
Abstract:Background. Diabetes is one of the common chronic diseases in which susceptibility is determined by a combination of genetic and environmental factors, and more than 90% of diabetic patients are diabetes mellitus type 2 (T2DM). The existing studies on the association between CDKAL1 rs10946398 gene polymorphism and susceptibility to type 2 diabetes are inconsistent across populations. Aim. We aim to explore the association between CDKAL1 rs10946398 gene polymorphism and susceptibility to type 2 diabetes in different populations. Methods. We examined all studies before June 12, 2021, that associated CDKAL1 rs10946398 with T2DM. Heterogeneity was assessed by meta-analysis of allelic inheritance models (A vs. C), dominant inheritance models (AA vs. AC+CC), and recessive inheritance model (AA+AC vs. CC); I 2 was used to assess the heterogeneity (if I 2 < 50 %, the fixed-effects model was used; if I 2 ≥ 50 %, the random-effects model was used for data consolidation); correlation was judged by a forest map; potential publication bias was tested by the Egger test ( p > 0.05 indicates that there is no publication bias). Results. Fourteen data totaling 30288 subjects, including 19272 controls and 11016 patients with T2DM, met our inclusion criteria. In the Asian population, the differences were statistically significant ( p < 0.01 ) for dominant genetic model ( OR = 0.75 , 95 % CI = 0.64 -0.88, p = 0.0003 ). But the allelic effect model ( OR = 0.87 , 95 % CI = 0.75 -1.02, p = 0.08 ) and the recessive genetic model ( OR = 0.85 , 95 % CI = 0.66 -1.10, p = 0.23 ) were not statistically significant ( p > 0.01 ). In the non-Asian population, the differences were statistically significant ( p < 0.01 ) for the allelic effect model ( OR = 0.83 , 95 % CI = 0.77 -0.88, p < 0.00001 ), the dominant model ( OR = 0.79 , 95 % CI = 0.72 -0.87, p < 0.00001 ), and the recessive model ( OR = 0.78 , 95 % CI = 0.70 -0.87, p < 0.0001 ). Conclusion. In this study, CDKAL1 RS10946398 was positively associated with T2DM, but the association was different in Asian populations.
endocrinology & metabolism,medicine, research & experimental
-
Interactions Between Zinc Transporter-8 Gene (SLC30A8) and Plasma Zinc Concentrations for Impaired Glucose Regulation and Type 2 Diabetes.
Zhilei Shan,Wei Bao,Yan Zhang,Ying Rong,Xia Wang,Yilin Jin,Yadong Song,Ping Yao,Changhao Sun,Frank B. Hu,Liegang Liu
DOI: https://doi.org/10.2337/db13-0606
IF: 7.7
2013-01-01
Diabetes
Abstract:Although both SLC30A8 rs13266634 single nucleotide polymorphism and plasma zinc concentrations have been associated with impaired glucose regulation (IGR) and type 2 diabetes (T2D), their interactions for IGR and T2D remain unclear. Therefore, to assess zinc-SLC30A8 interactions, we performed a case-control study in 1,796 participants: 218 newly diagnosed IGR patients, 785 newly diagnosed T2D patients, and 793 individuals with normal glucose tolerance. After adjustment for age, sex, BMI, family history of diabetes, and hypertension, the multivariable odds ratio (OR) of T2D associated with a 10 µg/dL higher plasma zinc level was 0.87 (95% CI 0.85–0.90). Meanwhile, the OR of SLC30A8 rs13266634 homozygous genotypes CC compared with TT was 1.53 (1.11–2.09) for T2D. Similar associations were found in IGR and IGR&T2D groups. Each 10 µg/dL increment of plasma zinc was associated with 22% (OR 0.78 [0.72–0.85]) lower odds of T2D in TT genotype carriers, 17% (0.83 [0.80–0.87]) lower odds in CT genotype carriers, and 7% (0.93 [0.90–0.97]) lower odds in CC genotype carriers (P for interaction = 0.01). Our study suggested that the C allele of rs13266634 was associated with higher odds of T2D, and higher plasma zinc was associated with lower odds. The inverse association of plasma zinc concentrations with T2D was modified by SLC30A8 rs13266634. Further studies are warranted to confirm our findings and clarify the mechanisms underlying the interaction between plasma zinc and the SLC30A8 gene in relation to T2D.
-
Association Between TCF7L2gene Polymorphisms and Susceptibility to Type 2 Diabetes Mellitus: a Large Human Genome Epidemiology (huge) Review and Meta-Analysis
Yu Tong
DOI: https://doi.org/10.1186/1471-2350-10-15
2009-01-01
BMC Medical Genetics
Abstract:AbstractBackgroundTranscription factor 7-like 2 (TCF7L2) has been shown to be associated with type 2 diabetes mellitus (T2MD) in multiple ethnic groups in the past two years, but, contradictory results were reported for Chinese and Pima Indian populations. The authors then performed a large meta-analysis of 36 studies examining the association of type 2 diabetes mellitus (T2DM) with polymorphisms in theTCF7L2gene in various ethnicities, containing rs7903146 C-to-T (IVS3C>T), rs7901695 T-to-C (IVS3T>C), a rs12255372 G-to-T (IVS4G>T), and rs11196205 G-to-C (IVS4G>C) polymorphisms and to evaluate the size of gene effect and the possible genetic mode of action.MethodsLiterature-based searching was conducted to collect data and three methods, that is, fixed-effects, random-effects and Bayesian multivariate mete-analysis, were performed to pool the odds ratio (OR). Publication bias and study-between heterogeneity were also examined.ResultsThe studies included 35,843 cases of T2DM and 39,123 controls, using mainly primary data. For T2DM and IVS3C>T polymorphism, the BayesianORfor TT homozygotes and TC heterozygotes versus CC homozygote was 1.968 (95% credible interval (CrI): 1.790, 2.157), 1.406 (95%CrI: 1.341, 1.476), respectively, and the population attributable risk (PAR) for the TT/TC genotypes of this variant is 16.9% for overall. For T2DM and IVS4G>T polymorphism, TT homozygotes and TG heterozygotes versus GG homozygote was 1.885 (95%CrI: 1.698, 2.088), 1.360 (95%CrI: 1.291, 1.433), respectively. FourORs among these two polymorphisms all yielded significant between-study heterogeneity (P < 0.05) and the main source of heterogeneity was ethnic differences. Data also showed significant associations between T2DM and the other two polymorphisms, but with low heterogeneity (P> 0.10). PooledORs fit a codominant, multiplicative genetic model for all the four polymorphisms ofTCF7L2gene, and this model was also confirmed in different ethnic populations when stratification of IVS3C>T and IVS4G>T polymorphisms except for Africans, where a dominant, additive genetic mode is suggested for IVS3C>T polymorphism.ConclusionThis meta-analysis demonstrates that four variants ofTCF7L2gene are all associated with T2DM, and indicates a multiplicative genetic model for all the four polymorphisms, as well as suggests theTCF7L2gene involved in near 1/5 of all T2MD. Potential gene-gene and gene-environmental interactions by which common variants in theTCF7L2gene influence the risk of T2MD need further exploration.
-
Association Between KCNJ11 Gene Polymorphisms and Risk of Type 2 Diabetes Mellitus in East Asian Populations: a Meta-Analysis in 42,573 Individuals
Lijuan Yang,Xianghai Zhou,Yingying Luo,Xiuqin Sun,Yong Tang,Wulan Guo,Xueyao Han,Linong Ji
DOI: https://doi.org/10.1007/s11033-011-0782-6
IF: 2.7422
2011-01-01
Molecular Biology Reports
Abstract:A number of studies have been performed to identify the association between potassium inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) gene and type 2 diabetes mellitus (T2DM) in East Asian populations, with inconsistent results. The main aim of this work was to evaluate more precisely the genetic influence of KCNJ11 on T2DM in East Asian populations by means of a meta-analysis. We identified 20 articles for qualitative analysis and 16 were eligible for quantitative analysis (meta-analysis) by database searching up to May 2010. The association was assessed under different genetic models, and the pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated. The allelic and genotypic contrast demonstrated that the association between KCNJ11 and T2DM was significant for rs5210. However, not all results for rs5215 and rs5218 showed significant associations. For rs5219, the combined ORs (95% CIs) for allelic contrast, dominant and recessive models contrast (with allelic frequency and genotypic distribution data) were 1.139 (1.093–1.188), 1.177 (1.099–1.259) and 1.207 (1.094–1.332), respectively (random effect model). The analysis on the most completely adjusted ORs (95% CIs) by the covariates of rs5219 all presented significant associations under different genetic models. Population-stratified analysis (Korean, Japanese and Chinese) and sensitivity analysis verified the significant results. Cumulative meta-analysis including publication time and sample size illustrated the exaggerated genetic effect in the earliest studies. Heterogeneity and publication bias were assessed. Our study verified that single nucleotide polymorphisms (SNPs) of KCNJ11 gene were significantly associated with the risk of T2DM in East Asian populations.
-
Correlation between CDKAL1 rs10946398C>A single nucleotide polymorphism and type 2 diabetes mellitus susceptibility: A meta-analysis
Yunyi Liang,Yi Shu,Haizhao Luo,Riqiu Chen,Zhifu Zeng
DOI: https://doi.org/10.1515/biol-2017-0059
2017-12-29
Open Life Sciences
Abstract:Abstract Objective The purpose of this meta analysis was to assess the correlation between CDKAL1 rs10946398C>A single nucleotide polymorphism (SNP) and type 2 diabetes mellitus (T2DM) susceptibility by pooling the open published studies. Method Electronic searching of PubMed, EMBASE, Medline, Cochrane, China Biology Medicine disc (CBM) and China National Knowledge Infrastructure (CNKI) databases were performed by two reviewers independently to collect the open published studies related to CDKAL1 rs10946398C>A single nucleotide polymorphism and T2DM susceptibility. The association between CDKAL1 rs10946398C>A single nucleotide polymorphism and T2DM susceptibility was expressed by odds ratio (OR) and the corresponding 95% confidence interval (95%CI). Results Thirteen studies with a total of 13,966 T2DM and 14,274 controls were finally included for analysis in this meta-analysis. Of the included 13 publications, 2 studies were carried out in Europe, 8 in Asia, 2 in Africa and 1 in Latin America. Being significant statistical heterogeneity, the data was pooled through random effect model. In a dominant genetic model, there was significant correlation between CDKAL1 rs10946398C>A SNP and T2DM risk (OR=1.22, P<0.05). In a dominant genetic model people with CC or CA genotype had increased risk of developing T2DM; Because of statistical heterogeneity for the included studies in a recessive genetic model (AA+CA vs CC), the data was calculated by random effect method. The combined data showed people with AA or CA genotype had decreased risk of developing T2DM compared to CC genotype (OR=0.83, P<0.05); For a homozygous genetic model (CC vs AA), the OR was calculated through random effect model for statistical heterogeneity among the included 13 studies. The combined OR was 1.33 which indicated people with CC genotype had increased risk of developing T2DM. Conclusion According to the present results, CDKAL1 rs10946398C>A single nucleotide polymorphism had correlation with the susceptibility of type 2 diabetes mellitus.
biology
-
Relationship Between SLC22A1 and SLC22A4 Gene Polymorphisms and Risk of Type 2 Diabetes in Chinese Han Population.
Guanghui Long,Guangtao Zhang,Fangting Zhang,Dongshuo Ye,Dengke Yang,Yinke Yang
DOI: https://doi.org/10.7754/clin.lab.2018.180129
IF: 1.053
2018-01-01
Clinical Laboratory
Abstract:BACKGROUND:This study was to investigate the relationship between SLC22A1 and SLC22A4 gene polymorphisms and genetic susceptibility to type 2 diabetes in Chinese Han population. METHODS:The research group comprised 110 Chinese Han patients with type 2 diabetes, and the control group included 110 healthy volunteers. The polymorphisms of SLC22A1 gene rs628031 and rs2282143 loci and SLC22A4 gene rs2073838 and rs272893 loci were detected in the two groups. RESULTS:Statistically significant differences were identified in the genotype distributions of SLC22A1 gene rs628031 and rs2282143 loci between the two groups (p < 0.05). The A allele frequency of SLC22A1 gene rs628031 locus and the T allele frequency of rs2282143 locus were higher in the research group than in the control group (p < 0.05). The genotype distributions of rs272893 locus showed a significant difference between the two groups (p < 0.05), but not SLC22A4 gene rs2073838 locus (p > 0.05). CONCLUSIONS:The polymorphisms of SLC22A1 gene rs628031 and rs2282143 loci and SLC22A4 gene rs272893 locus of patients with type 2 diabetes indicated a significant difference between the two groups, suggesting that these genetic locus mutations increase the risk of type 2 diabetes in Chinese Han patients.
-
Association between the MCP-1 -2518 A > G (rs1024611) polymorphism and susceptibility to type 2 diabetes mellitus and diabetic nephropathy: a meta-analysis
Wei-Wei Chang,Liu Zhang,Li-Ying Wen,Yu-Jing Tao,Jia-Jie Xiong,Xin Tong,Yue-Long Jin,Hong Su
DOI: https://doi.org/10.1186/s12902-023-01514-z
2023-12-04
Abstract:Background: Studies evaluating the association between monocyte chemoattractant protein-1 (MCP-1) -2518 A > G (rs1024611) polymorphism and type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN) are contradictory. The present study aims to provide a comprehensive assessment and more reliable estimation of the relationship between the MCP-1 rs1024611 polymorphism and T2DM and DN risk. Methods: Eligible articles were retrieved from the PubMed, Web of Science, EMBASE, Cochrane, and China National Knowledge Infrastructure databases. The effect summary odds ratios (ORs) and 95% confidence intervals (CIs) were obtained to calculate the summary effect size. Heterogeneity was analyzed by subgroup analysis and meta-regression. Publication bias was tested using funnel plots and Egger's test. Results: In total, sixteen studies were included. Thirteen studies involving 2,363 patients with T2DM and 4,650 healthy controls found no significant association between the MCP-1 rs1024611 polymorphism and T2DM in the overall population. Ethnicity stratification found an association between the GG + GA genotype and decreased T2DM risk in Caucasians (OR = 0.79, 95% CI: 0.66-0.93, P = 0.006; PQ = 0.372). No significant risks were found in the Asian population for any genetic models. Seven studies found an association between the GG + GA genotype and DN risk in the Asian population (OR = 1.37, 95% CI: 1.11-1.71, P = 0.004, PQ = 0.222). No significant risks were found in the Caucasian population with any genetic models. There were no statistically significant differences in genotype distribution between patients with T2DM and DN in Asians or Caucasians. Meta-regression revealed that genotyping method was a major driver of heterogeneity in five genetic models (GG + GA vs. AA: P = 0.032; GG vs. GA + AA: P = 0.028; GG vs. AA: P = 0.035; GG vs. GA: P = 0.041; G vs. A: P = 0.041). Conclusion: The MCP-1 rs1024611 polymorphism is associated with susceptibility to T2DM in Caucasians and DN in Asians. Larger, well-designed cohort studies are needed in the future to verify this association.
-
Association Between IGF2BP2 Polymorphisms and Type 2 Diabetes Mellitus: A Case–Control Study and Meta-Analysis
Ping Rao,Hao Wang,Honghong Fang,Qing Gao,Jie Zhang,Manshu Song,Yong Zhou,Youxin Wang,Wei Wang
DOI: https://doi.org/10.3390/ijerph13060574
2016-01-01
Abstract:Background: Genome-wide association studies (GWAS) found that IGF2BP2 rs4402960 and rs1470579 polymorphisms were associated with type 2 diabetes mellitus (T2DM) risk. Many studies have replicated this association, but yielded inconsistent results. Materials and Methods: A case-control study consisting of 461 T2DM patients and 434 health controls was conducted to detect the genetic susceptibility of IGF2BP2 in a northern Han Chinese population. A meta-analysis was to evaluate the association more precisely in Asians. Results: In the case-control study, the carriers of TT genotype at rs4402960 had a higher T2DM risk than the G carriers (TG + GG) (adjusted odd ratio (AOR) = 1.962, 95% confidence interval (95% CI) = 1.065–3.612, p = 0.031]; CC carriers at rs1470579 were more susceptible to T2DM than A carriers (CA + AA) (AOR = 2.014, 95% CI = 1.114–3.642, p = 0.021). The meta-analysis containing 36 studies demonstrated that the two polymorphisms were associated with T2DM under the allele comparison, genetic models of dominant and recessive in Asians (p < 0.05). The rs4402960 polymorphisms were significantly associated with the T2DM risk after stratification by diagnostic criterion, size of sample and average age and BMI of cases, while there’re no consistent results for rs1470579. Conclusions: Our data suggests that IGF2BP2 polymorphisms are associated with T2DM in Asian populations.
-
Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis
Aiyu Peng,Chunmei Gong,Yuanfei Xu,Xiongshun Liang,Xiaoping Chen,Wenxu Hong,Junxia Yan
DOI: https://doi.org/10.3389/fpubh.2023.1183879
2023-07-21
Abstract:Background: Variants in organic cation transporter (OCT) genes play a crucial role in metformin pharmacokinetics and are critical for diabetes treatment. However, studies investigating the effect of OCT genetic polymorphisms on metformin response have reported inconsistent results. This review and meta-analysis aimed to evaluate the associations between OCT genetic polymorphisms and metformin response and intolerance in individuals with type 2 diabetes mellitus (T2DM). Method: A systematic search was conducted on PubMed, EMBASE, CNKI, WANFANG DATA, and VIP database for identifying potential studies up to 10 November 2022. The Q-Genie tool was used to evaluate the quality of included studies. Pooled odds ratios (OR) or standardized mean differences (SMD) and 95% confidence intervals (95% CI) were calculated to determine the associations between OCT genetic polymorphisms and metformin response and intolerance that were reflected by glycemic response indexes, such as glycated hemoglobin level (HbA1c%) or change in glycated hemoglobin level (ΔHbA1c%), fasting plasma level (FPG) or change in fasting plasma glucose level (ΔFPG), the effectiveness rate of metformin treatment, and the rate of metformin intolerance. A qualitative review was performed for the variants identified just in one study and those that could not undergo pooling analysis. Results: A total of 30 related eligible studies about OCT genes (SLC22A1, SLC22A2, and SLC22A3) and metformin pharmacogenetics were identified, and 14, 3, and 6 single nucleotide polymorphisms (SNPs) in SLC22A1, SLC22A2, and SLC22A3, respectively, were investigated. Meta-analysis showed that the SLC22A1 rs622342 polymorphism was associated with a reduction in HbA1c level (AA vs. AC: SMD [95% CI] = -0.45 [-0.73--0.18]; p = 0.001). The GG genotype of the SLC22A1 rs628031 polymorphism was associated with a reduction in FPG level (GG vs. AA: SMD [95 %CI] = -0.60 [-1.04-0.16], p = 0.007; GG vs. AG: -0.45 [-0.67-0.20], p < 0.001). No statistical association was found between the remaining variants and metformin response and intolerance. Conclusion: SLC22A1 rs622342 and rs628031 polymorphisms were potentially associated with glycemic response to metformin. This evidence may provide novel insight into gene-oriented personalized medicine for diabetes.
-
Association Between the Melatonin Receptor 1B Gene Polymorphism on the Risk of Type 2 Diabetes, Impaired Glucose Regulation: a Meta-Analysis.
Qing Xia,Zi-Xian Chen,Yi-Chao Wang,Yu-Shui Ma,Feng Zhang,Wu Che,Da Fu,Xiao-Feng Wang
DOI: https://doi.org/10.1371/journal.pone.0050107
IF: 3.7
2012-01-01
PLoS ONE
Abstract:Background: Melatonin receptor 1B (MTNR1B) belongs to the seven-transmembrane G protein-coupled receptor superfamily involved in insulin secretion, which has attracted considerable attention as a candidate gene for type 2 diabetes (T2D) since it was first identified as a loci associated with fasting plasma glucose level through genome wide association approach. The relationship between MTNR1B and T2D has been reported in various ethnic groups. The aim of this study was to consolidate and summarize published data on the potential of MTNR1B polymorphisms in T2D risk prediction.Methods: PubMed, EMBASE, ISI web of science and the CNKI databases were systematically searched to identify relevant studies. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Heterogeneity and publication bias were also tested.Results: A total of 23 studies involving 172,963 subjects for two common polymorphisms (rs10830963, rs1387153) on MTNR1B were included. An overall random effects per-allele OR of 1.05 (95% CI: 1.02-1.08; P<10(-4)) and 1.04 (95% CI: 0.98-1.10; P = 0.20) were found for the two variants respectively. Similar results were also observed using dominant or recessive genetic model. There was strong evidence of heterogeneity, which largely disappeared after stratification by ethnicity. Significant results were found in Caucasians when stratified by ethnicity; while no significant associations were observed in East Asians and South Asians. Besides, we found that the rs10830963 polymorphism is a risk factor associated with increased impaired glucose regulation susceptibility.Conclusions: This meta-analysis demonstrated that the rs10830963 polymorphism is a risk factor for developing impaired glucose regulation and T2D.
-
Association of Rs12255372 in the Tcf7l2 Gene with Type 2 Diabetes Mellitus: A Meta-Analysis
Jinjin Wang,Jianfeng Zhang,Linlin Li,Yan Wang,Qian Wang,Yujia Zhai,Haifei You,Dongsheng Hu
DOI: https://doi.org/10.1590/1414-431x20132677
2013-01-01
Brazilian Journal of Medical and Biological Research
Abstract:Our objective was to evaluate the association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus (T2DM) in the world population. We carried out a survey of the literature about the effect of rs12255372 on genetic susceptibility to T2DM by consulting PubMed, the Cochrane Library, and Embase from 2006 to 2012, and then performed a meta-analysis of all the studies in order to evaluate the association between rs12255372 and T2DM. A total of 33 articles including 42 studies (with 34, 076 cases and 36, 192 controls) were confirmed to be eligible and were included in the final meta-analysis: 6 studies conducted on Europeans, 14 on Caucasians, 17 on Asians, 2 on Africans, and 3 on Americans. Overall, the effect size was as follows: for the variant allele T (OR = 1.387, 95% CI = 1.351-1.424), for the TT genotype (OR = 1.933, 95% CI = 1.815-2.057), for the GT genotype (OR = 1.363, 95% CI = 1.315-1.413), for the dominant model (OR = 1.425, 95% CI = 1.344-1.510), and for the recessive model (OR = 1.659, 95% CI = 1.563-1.761). In summary, by pooling all available qualified data from genetic studies on rs12255372 and T2DM, we have confirmed that rs12255372 is significantly associated with susceptibility to T2DM in the global population.